Patent assignee · IN · COMPANY

Jubilant Generics Limited

19Patents
19Active
19Granted
50Portfolio score

Filing activity: Nov 20, 2006 → Aug 27, 2021 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8865212B2 Stable pharmaceutical formulation of an acid labile compound and process for preparing the same Human Necessities 6 Active
US10537562B2 Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof Human Necessities 2 Active
US10888519B2 Immediate release pharmaceutical composition of iron chelating agents Human Necessities 2 Active
US11020349B1 Transmucosal dosage forms of remdesivir Human Necessities 1 Active
US11331324B2 Modified release suspension of eslicarbazepine Human Necessities 0 Active
US10946002B2 Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof Human Necessities 0 Active
US10426770B2 Process for the preparation of Lurasidone hydrochloride Chemistry; Metallurgy 0 Active
US10016374B2 Disintegrant free composition of Cinacalcet Human Necessities 0 Active
US10918604B2 Solid oral dosage forms of eslicarbazepine Human Necessities 0 Active
US10813916B2 Immediate release pharmaceutical composition of tizanidine Human Necessities 0 Active
US11471543B2 Pharmaceutical compositions of sulfur colloid and processes thereof Human Necessities 0 Active
US10918630B2 Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof Human Necessities 0 Active
US10889549B2 Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof Performing Operations; Transporting 0 Active
US10252986B2 Process for the preparation of exametazime Chemistry; Metallurgy 0 Active
US10836781B2 Process for the preparation of tetrofosmin or acid salt thereof Chemistry; Metallurgy 0 Active
US11327065B1 Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof Physics 0 Active
US11642351B2 Eslicarbazepine suspension Human Necessities 0 Active
US11318145B2 Eslicarbazepine suspension Human Necessities 0 Active
US9932336B2 Process for the preparation of apixaban and intermediates thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.